Elicio Therapeutics

Elicio Therapeutics is a clinical-stage biotechnology company focused on developing next-generation immunotherapies specifically for KRAS-driven cancers. With a commitment to personalized cancer treatment, their innovative AMP technology enhances the activation and amplification of cancer-fighting T cells, offering a promising approach to achieving durable responses in patients.